NYSE undervalued ranking
Ranked by the GARP strategy. Lower valuation ranks higher. · Healthcare
Data as of: 2026-10-30 · end-of-day, not real-time
Information & education only — not investment advice or a guarantee of returns.
Best Undervalued NYSE Stocks (2026) →
Best Balanced NYSE Stocks (2026) →
💡 Preset screens
GARP — Growth at a reasonable price (low PEG)
Built from: PEG · Forward P/E · Earnings Growth
Details →14 stocks · 2 value-trap stocks hidden
Return periodtrading days (holidays excluded)
Sort
1CVS Health CorporationCVS NYSE · HealthcareP/E23.888.9
Mkt Cap
$115.4B
P/E
23.8
P/B
1.4
1M
+5.1%
2AbbVie Inc.ABBV NYSE · HealthcareP/E83.371.8①
Mkt Cap
$521.1B
P/E
83.3
P/B
–
1M
+12.9%
3UnitedHealth Group IncorporatedUNH NYSE · HealthcareP/E23.259.2
Mkt Cap
$365.3B
P/E
23.2
P/B
3.5
1M
+9.4%
4Medtronic plc.MDT NYSE · HealthcareP/E23.745.2
Mkt Cap
$123.5B
P/E
23.7
P/B
2.5
1M
+11.8%
5AstraZeneca PLCAZN NYSE · HealthcareP/E27.944.2
Mkt Cap
$289.5B
P/E
27.9
P/B
5.8
1M
+19.0%
6Danaher CorporationDHR NYSE · HealthcareP/E38.442.8
Mkt Cap
$163.3B
P/E
38.4
P/B
3.0
1M
+8.5%
7Eli Lilly and CompanyLLY NYSE · HealthcareP/E47.637.1①
Mkt Cap
$1.26T
P/E
47.6
P/B
47.8
1M
+24.0%
8Bristol-Myers Squibb CompanyBMY NYSE · HealthcareP/E13.829.4①
Mkt Cap
$127.7B
P/E
13.8
P/B
6.9
1M
+2.2%
9Pfizer Inc.PFE NYSE · HealthcareP/E40.228.1①
Mkt Cap
$174.0B
P/E
40.2
P/B
2.0
1M
+9.8%
10McKesson CorporationMCK NYSE · HealthcareP/E26.726.9①
Mkt Cap
$116.0B
P/E
26.7
P/B
–
1M
+10.2%
11Thermo Fisher Scientific IncTMO NYSE · HealthcareP/E36.825.4
Mkt Cap
$257.7B
P/E
36.8
P/B
4.7
1M
+6.4%
12Merck & Company Inc.MRK NYSE · HealthcareP/E118.723.2①
Mkt Cap
$368.9B
P/E
118.7
P/B
8.8
1M
+3.6%
13Novartis AGNVS NYSE · HealthcareP/E30.716.7
Mkt Cap
$303.7B
P/E
30.7
P/B
8.2
1M
+14.0%
14Johnson & JohnsonJNJ NYSE · HealthcareP/E41.511.0
Mkt Cap
$657.7B
P/E
41.5
P/B
8.1
1M
+6.7%